MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Expanding the Spectrum of Alzheimer’s Disease Clinical Presentations: Progressive Dysarthria with Monomelic Tremor

    O. Carranza-Renteria, G. Gliebus (Boca Raton, USA)

    Objective: To present an unusual clinical presentation of an atypical Corticobasilar syndrome secondary to Alzheimer's disease. Background: Corticobasilar syndrome (CBS) typically presents with motor symptoms…
  • 2025 International Congress

    Exploring the Role of Aperiodic and Periodic Spectral Activity in Guiding Deep Brain Stimulation Electrode Selection for Childhood Dystonia

    T. Larsh, S. Vadivelu, J. Skoch, T. Lipps, D. Gilbert, S. Wu (Cincinnati, USA)

    Objective: To evaluate the potential of aperiodic and periodic neural activity in guiding clinical deep brain stimulation (DBS) programming for children with dystonia. Background: DBS…
  • 2025 International Congress

    Advancing Hypomimia Assessment in Parkinson’s Disease by Integrating a Continuous Monitoring Device into Clinical Practice

    A. Wiederhold, C. Gundler (Hamburg, Germany)

    Objective: We aim to establish a robust, continuous method for monitoring hypomimia in Parkinson’s disease (PD), bridging the gap between sporadic clinical evaluations and real-life…
  • 2025 International Congress

    Neurological manifestations and genotypes of Gaucher disease type 3: MDSGene systematic review

    S. Schaake, T. Usnich, J. Boehm, N. Steffen, N. Schell, C. Krüger, T. Gül-Demirkale, N. Bahr, T. Kleinz, H. Madoev, B. Laabs, Z. Gan-Or, R. Alcalay, C. Marras, K. Lohmann, C. Klein, M. Rossi (Luebeck, Germany)

    Objective: To characterize the spectrum of neurological manifestations of Gaucher disease type 3 (GD3) and identify the most common GBA1 variants. Background: Gaucher disease is…
  • 2025 International Congress

    The Impact of Non-Invasive Brain Stimulation Timing on Physiotherapy Outcomes for Parkinson’s Disease a Systematic Review with Dose-Response Analysis

    M. Guidetti, E. Ravizzotti, S. Giannoni-Luza, NV. Maiorana, S. Marceglia, T. Bocci, S. Oliveri, E. Pelosin, R. Pagani, AM. Previtera, A. Priori (Milan, Italy)

    Objective: To determine the best timing for non-invasive brain stimulation (NIBS) intervention to enhance physiotherapy-induced motor recovery in patients with Parkinson's disease (PwPD), and to…
  • 2025 International Congress

    Normal Pressure Hydrocephalus in Vestibular Schwannoma Patients

    T. Davidy, S. Anis, T. Goldberg, A. Fay-Karmon, Y. Zauberman, N. Rennert, O. Lesman-Segev, S. Hassin-Baer (Cleveland, USA)

    Objective: The first objective is to evaluate the potential pathophysiological link between vestibular schwannoma (VS) and normal pressure hydrocephalus (NPH) by analyzing clinical features, imaging…
  • 2025 International Congress

    Validation of the Short Progressive Supranuclear Palsy Quality of Life Scale in PSPNI

    Q. Shen, XY. Li, J. Wang, FT. Liu (Shanghai, China)

    Objective: This study aimed to evaluate the reliability, validity, and sensitivity to change of the PSP-ShoQoL in PSPNI, a longitudinal Chinese PSP cohort. Background: Self-reported…
  • 2025 International Congress

    Altered Tryptophan Metabolism and the Role of the Kynurenine Pathway in Multiple System Atrophy

    R. Nagao, K. Kawabata, Y. Mizutani, H. Watanabe (Toyoake, Japan)

    Objective: To elucidate cerebrospinal fluid (CSF) tryptophan metabolism in multiple system atrophy (MSA), focusing on alterations in the kynurenine pathway and its pathological implications. Background:…
  • 2025 International Congress

    Examining Disparities and Device Usage in Outpatient Telemedicine Visits Amongst Movement Disorders Patients

    V. Palakuzhy, B. Ouyang, G. Stebbins, C. Goetz, M. Afshari (Chicago, USA)

    Objective: To characterize trends in device usage (mobile-device vs. personal computer (PC)) across demographic factors for video-based telemedicine visits in an urban tertiary Movement Disorders…
  • 2025 International Congress

    Phenotypic Spectrum In Children And Adolescents With Glucose Transporter 1 Deficiency A Multicentric Retrospective Study

    S. Yoganathan, C. Pefaur, V. Gowda, V. Cornejo, V. Quiroz, P. Jain, S. Sharma, L. Guilder, G. Costain, I. Tein, C. Gorodetksy (Toronto, Canada)

    Objective: To describe the spectrum of phenotypes in children and adolescents with biochemically and/or genetically proven Glucose Transporter 1 (GLUT1) deficiency. Background: The phenotypes in…
  • « Previous Page
  • 1
  • …
  • 113
  • 114
  • 115
  • 116
  • 117
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley